Insider Trading activities of Corvus Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Corvus Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Corvus Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Corvus Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is CRVS. The reporting company's CIK number is 1626971.
The total value of stock buying since 2005 is $36,045,705.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Corvus Pharmaceuticals, Inc. (CRVS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 45,000 $466,047 0 $0 0 $0
2016-06 218,766 $2,794,548 0 $0 0 $0
2016-05 23,032 $285,120 0 $0 0 $0
2016-03 2,166,666 $32,499,990 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Corvus Pharmaceuticals, Inc. insiders (CRVS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-23 Novo Holdings A/s (10% Owner) Buy 20,000 10.95 219,000
2017-06-13 Miller Richard A Md (President and CEO) Buy 5,000 9.95 49,725
2017-06-12 Miller Richard A Md (President and CEO) Buy 11,216 9.82 110,185
2017-06-09 Miller Richard A Md (President and CEO) Buy 8,784 9.92 87,137
2016-06-24 Thompson Peter A. Buy 900 12.99 11,691
2016-06-24 Isaly Samuel D Buy 900 12.99 11,691
2016-06-23 Thompson Peter A. Buy 100 12.92 1,292
2016-06-23 Isaly Samuel D Buy 100 12.92 1,292
2016-06-21 Thompson Peter A. Buy 26,083 12.87 335,688
2016-06-21 Isaly Samuel D Buy 26,083 12.87 335,688
2016-06-17 Thompson Peter A. Buy 12,300 12.48 153,504
2016-06-17 Isaly Samuel D Buy 12,300 12.48 153,504
2016-06-16 Thompson Peter A. Buy 5,000 12.04 60,199
2016-06-16 Isaly Samuel D Buy 5,000 12.04 60,199
2016-06-15 Thompson Peter A. Buy 5,000 11.94 59,700
2016-06-15 Isaly Samuel D Buy 5,000 11.94 59,700
2016-06-14 Thompson Peter A. Buy 10,000 12.71 127,100
2016-06-14 Isaly Samuel D Buy 10,000 12.71 127,100
2016-06-10 Thompson Peter A. Buy 20,000 12.98 259,600
2016-06-10 Isaly Samuel D Buy 20,000 12.98 259,600
2016-06-09 Thompson Peter A. Buy 30,000 12.95 388,500
2016-06-09 Isaly Samuel D Buy 30,000 12.95 388,500
2016-05-20 Thompson Peter A. Buy 4,716 13.09 61,732
2016-05-20 Isaly Samuel D Buy 4,716 13.09 61,732
2016-05-19 Thompson Peter A. Buy 2,600 12.43 32,318
2016-05-19 Isaly Samuel D Buy 2,600 12.43 32,318
2016-05-18 Thompson Peter A. Buy 4,200 11.55 48,510
2016-05-18 Isaly Samuel D Buy 4,200 11.55 48,510
2016-03-29 Gould Terry P (Director) Buy 200,000 15.00 3,000,000
2016-03-29 Novo A/s (10% Owner) Buy 666,666 15.00 9,999,990
2016-03-29 Thompson Peter A. (Director) Buy 550,000 15.00 8,250,000
2016-03-29 Adams Street Partners Llc (10% Owner) Buy 200,000 15.00 3,000,000
2016-03-29 Orbimed Advisors Llc (Director) Buy 550,000 15.00 8,250,000

Insider trading activities including stock purchases, stock sales, and option exercises of CRVS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Corvus Pharmaceuticals, Inc. (symbol CRVS, CIK number 1626971) see the Securities and Exchange Commission (SEC) website.